MedImmune and Micromet AG, a wholly owned subsidiary of Micromet, Inc., will receive a milestone payment from MedImmune triggered by the IND filing. Micromet’s Proprietary BiTE® Platform has Potential to Improve Treatment in Multiple Tumor Types. All-Cash Transaction Values Micromet at. The initial development plan contemplates EUR 25 million in funding of Micromet R&D activities if two BiTE antibodies are advanced to IND.
|Published (Last):||6 September 2011|
|PDF File Size:||15.30 Mb|
|ePub File Size:||2.61 Mb|
|Price:||Free* [*Free Regsitration Required]|
Good News for Micromet
Micromet could also earn up to double-digit royalties on worldwide net sales. Micromet has established collaborations with MedImmune, Inc.
This is the second highest pollution level of this year. New York, Aug 30 IANS In a finding that could make the process of removing salt from seawater easier, faster and cheaper than ever before, researchers have discovered that carbon nanotubes of a certain size act as the perfect filter for salt — the most abundant water contaminant.
Through the killing process, T cells start to proliferate, which leads to an increased number of T cells at the site of attack. Moreover, the heavy dependence on blinatumomab is also a concern — any hiccup in its clinical development programs will weigh heavily on the stock. Nid offices to be located in the Washington, DC area.
Prior to joining Genaera, Mr. The air conditioning system in the new Tesla Model X has three modes: MedImmune made a milestone payment to Micromet following the submission of the IND for MT, which demonstrated anti-tumor growth features in pre-clinical studies. Currently, we have a Neutral recommendation on Micromet. TomorrowMakers Let’s get smarter about money.
All News Videos Photos. Log in to leave a comment. Top 25 Biotech Companies of In the presence of BiTE antibodies, T cells micdomet been demonstrated to serially eliminate tumor cells, which explains the activity of BiTE antibodies at very low concentrations.
ET EnergyWorld A one stop platform that caters to the pulse of the pulsating energy.
Amgen Pays $10M Up Front in Cancer Deal with Micromet
With Matthias Alder and Chris Schnittker, Micromet has made two key hires that are strengthening micrpmet senior management team and who will be instrumental in building out our U. Prior to joining Cytogen, Mr. Prior to that, Mr.
Government 4 Jul, We note that the most promising candidate at Micromet is blinatumomab MTalso being co-developed with MedImmune, for the treatment of acute lymphoblastic leukemia ALLa type of blood cancer.
Dental treatments burning a hole in your pocket?
New process to help desalinate water faster, cheaper 30 Aug, Now you can 3D print glass 23 Apr, Micromet will be primarily responsible for the discovery and preclinical development of the BiTE antibodies. The candidate is being developed to treat patients suffering from advanced gastrointestinal cancers. You won’t be able to use WhatsApp on these devices in The government today said that assistive devices for the physically-challenged will be charged at a concessional 5 per cent.
EPFO may give your money more stock play next year Updated: Delhi’s air quality turns ‘severe’: Schnittker received his B. Delhi records year’s second highest pollution level 23 Dec, TERI 17 Apr, MITIa biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases, today announced the appointment of Christopher P.
Amgen will lead the clinical development, manufacturing, and commercialization of any products resulting from the collaboration. The new biogenic products can rebuild teeth and cure cavities without costly and uncomfortable treatments. In addition to the finance, business development and legal functions, Micromet is planning to expand the US headquarters by adding micromt development team for US clinical trials and regulatory interactions with the FDA.
Good News for Micromet
Air pollutant concentrations “violated standards” at most places in Delhi on the second day of the odd-even scheme whose second phase has been rolled out in the national capital, TERI said.
Expands Management and Appoints Christopher P. Commercializing Continuous Processing in Pharma. Have you read these stories?